Home > Insider Trading > Filing (0001209191-14-012994)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367920	Concert Pharmaceuticals Inc.	CNCE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1190472	A Mark Wan	C/O Three Arch Partners 3200 Alpine Road Portola Valley CA 94028	No	No	Yes	No
1190474	E Wilfred Jaeger	C/O Three Arch Partners 3200 Alpine Road Portola Valley CA 94028	Yes	No	Yes	No
1269801	Three Arch Partners Iv Lp	3200 Alpine Road Portola Valley CA 94028	No	No	Yes	No
1276986	Three Arch Associates Iv Lp	3200 Alpine Road Portola Valley CA 94028	No	No	Yes	No
1365429	Three Arch Management Iv, L.l.c.	3200 Alpine Road Portola Valley CA 94028	Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-19	5,735	$0.00	6,289	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2014-02-19	7,647	$0.00	13,936	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2014-02-19	1,529	$0.00	15,465	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2014-02-19	259,751	$0.00	284,860	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2014-02-19	346,335	$0.00	631,195	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2014-02-19	69,267	$0.00	700,462	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2014-02-19	2,236	$14.00	17,701	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2014-02-19	101,264	$14.00	801,726	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2014-02-19	32,405	$0.00	5,735	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2014-02-19	43,206	$0.00	7,647	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2014-02-19	8,641	$0.00	1,529	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2014-02-19	1,467,595	$0.00	259,751	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2014-02-19	1,956,794	$0.00	346,335	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2014-02-19	391,359	$0.00	69,267	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The Series A, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-5.65 basis upon the closing of the issuer's initial public offering without payment of consideration.
These shares are owned directly by Three Arch Associates IV, L.P. ("TAA IV"). Three Arch Management IV, L.L.C. ("TAM IV") is the general partner of TAA IV, and Wilfred Jaeger and Mark Wan, the Managing Members of TAM IV, may be deemed to share voting and dispositive power over the shares held by TAA IV. Such persons and entities disclaim beneficial ownership of the shares held by TAA IV except to the extent of any pecuniary interest therein.
These shares are owned directly by Three Arch Partners IV, L.P. ("TAP IV"). Three Arch Management IV, L.L.C. ("TAM IV") is the general partner of TAP IV, and Wilfred Jaeger and Mark Wan, the Managing Members of TAM IV, may be deemed to share voting and dispositive power over the shares held by TAP IV. Such persons and entities disclaim beneficial ownership of the shares held by TAP IV except to the extent of any pecuniary interest therein.
Not applicable.